AI assistant
STAAR SURGICAL CO — Director's Dealing 2016
Jul 1, 2016
31996_dirs_2016-07-01_20cb1300-5328-484e-8138-c0573578d4e6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2016-06-24
Reporting Person: Holliday Keith (V.P., Research & Development)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 35041 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Common Stock Options | $7.20 | 2025-08-18 | Common Stock (25000) | Direct | |
| Common Stock Options | $7.52 | 2026-03-17 | Common Stock (25000) | Direct |
Footnotes
F1: Includes award of 12,500 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/18/17, 1/3 of the RSUs on 3/18/18, and the remaining 1/3 of the RSUs on 3/18/19.
F2: The "new hire" options granted on August 19, 2015 vested and became exercisable effective February 11, 2016, when the level of ownership of the Company's outstanding common stock by an investor reached a level that constituted a "Change in Control" under the Company's 2003 Amended and Restated Omnibus Equity Incentive Plan.
F3: The options granted on March 18, 2016 become exercisable as follows: 1/3 on 3/18/2017 and 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis.